ssti
history taking
e patient’s immune status, geographic locale, travel history, recent trauma or surgery, previous antimicrobial therapy, lifestyle, hobbies, and animal exposure or bites
CELLULITIS
CAUSES
VENOUS
LYMPHATIC COMPROMISE FROM PREVIOUS CELLULITIS
PERIPHERAL EDEMA
PREVIOUS RADIATION TO AN AREA
HX OF LYMPH NODE RESECTION
LYMPHEDEMA
OBESITY
TRAUMATIC LACERTION
CHRONIC DERMATOSES -W SKIN BREAKDOWN FROM ECZEMA /MACERATED TINEA PEDIS,BUG BITES SURGICAL WOUND INFECTIONS
THIS IS LEG CELLULITIS
cellullitis
ETIOLOGY
STAPH AUREUS
MRSA
MSSA
HEMOPHILUS INFLUENZAE( CHILDREN MORE COMMON)
RISK FACTORS
>80
PRIOR TRAUMA
UNTREATED FURUNCULOSIS
BURNS
DM
URI ( KIDS)
IMMUNOCOMPROMISE
BUG BITE
LACERATION
ASST FINDINGS
USUAL +
PAIN
FEVER
LYMPHADENOPATHY
FISSURING /MACERATION TOE WEBS-CAUSE
HISTORY OF RECURRENT ABSCESSES
DIFF DIAGNOSIS
ACUTE GOUT
ERYSIPELAS
STASIS DERMATITIS
CONTACT DERMATITIS
FOLLICULITIS
IMPETIGO
VZV
RUPTURED BAKERS CYST
ERYTHEMA MIGRANS
DIAGNOSTICS
CBC W DIFF-LEUCOCYTOSIS WITH LEFT SHIFT ( BANDS, NEUUTROPHILIA)
CREATININE,
BICARBONATE
CREATININE PHOSPHOKINASE’
CULTURE OF WOUND
GRAM STAIN
BLOOD CULTURE ( SEPSIS )
ESR ( ELEVATED)
IMAGING
CT /MRI IF OM SUSPECTED
MGT
PHARM
NON PHARM
MSSA AND B HEMOLYTIC STREPTOCOCCI
CEPHALEXIN 500 MG PO QQID X 5-7 DAYS
BACTRIM DS 1 TAB PO 5-10 DAYS , 14 DAYS IF COMPLEX
MRSA PLUS BHS
CLINDAMYCIN 300-450 PO Q 6 X 7 DAYS
MRSA SUSPECTED: HIBICLENS WASHES X 7 DAYS AND MUPIROCIN OINTMENT NARES BID OR TID X 56DAYS
MOIST HEAT
ELEVATION
F/U
REFERRAL
24-48-HOURS AFTER TREATMENT AND AS PT CONDITION DICTATES
MAY BE MRSA IF NOT RESPONDING TO KEFLEX
REFER ID OR ED
INFECTIONS FACE NECK SCALP
SEPSIS
SURGERY IF DRAINAGE NEEDED
IMMUNOCOMPROMISED PTS
bacterial skin infections
folliculitis
furunculosis
carbunculosis
Cutaneous Abscesses,
Inflamed Epidermoid Cysts)idsa
superficial infection of hair follicles
lesions small raised erythematous ,occasionally pruritic,<5mm
FURUNCULOSIS
DEEP INFECTION OF FOLLICLE
ROUND TENDER NODULE BECOMES PUSTULE OR PERIFOLLICULAR ABSCESS
NECK FACE BUTTOCKS WAISTLINE BREASTS
CARBUNCULOSIS
DEEP SUPPURATIVE LESION
EXTENDS INTO SC TISSUE
COALESCENCE OF SEVERAL FOLLICLES
PUS
CUTANEOUS ABSCESS: COLLECTION OF PUS WITHIN DERMIS AND DEEPER TISSUES
PAINFUL FLUCTUANT,SURMOUNTED BY PUSTULE
RIM OF ERYTHEMATOUS SWELLING
POLYMICROBIAL W REGIONAL SKIN FLORA-OFTEN STAPH OR MRSA (IDSA)
EPIDERMOID CYST
ERRONEOUSLY CALLED SEBACEOUS CYSTS
NORMAL SKIN FLORA IN A CHEESY KERATINOUS MATERIAL
INFLAMMATION AND PUS OCCURS AS A REACTION TO RUPTURE OF THE CYST WALL AND EXTRUSION OF CONTENTS INTO DERMIS ,RATHER THAN AN INFECTIOUS PROCESS(IDSA)
TREATMENT
SSE PPTX FOR ALGORITHM
F,F,C
CAUSE
MRSA COMMON OUTPATIENT SETTING
PSEUDOMONAS HOT TUB FOLLICULITIS
PITYROSPORUM FOLLICULITIS
FFC
INCIDENCE
F- ALL AGES RECURS-
SHAVING POOR HYGIENE ,WATER EXPOSURE,OCCLUSIVE STEROIDS THX
FU TEENS ADULTS RECURS
POOR HYGIENE, CROWDED , DM
C
MEN>WOMEN , AT RISK IMMUNO OLDER ADULTS, CHRONIC DISEASES
CHORNIC DX, DM ETOH ELDERLY
F FU C
F SUPERIFICAL HAIR COMES OUT OF FOLLICLE EASY, MILD ERYTHEMA
FC PUSTULE WITH CENTRAL NECROSIS AND CORE OF PUS PAIN INFLAMMATION EDEMA MAY NEED I&D
FEVER SLOW DEVELOP SLOUGH DRAINAGE MULTIPLE OPENINGS , NEEDS I&D
DIFF DX
PSUEDOFOLLICULITIS
ACNE V
CUTANEOUS CANDIDIASIS
KERTOSIS PILLARIS
FU'
FOLL, CARB, HS PILAR CYSTS
CA
CYSTIC ACNE
EPIDERMAL CYST
FOLL
HS
FISH TANK MYCOBACTERIUM MARINUM
PREVENTION FFUC
diagnostics
RECURRENT SEVERE
BETADINE OR HIBICLENS DAILY IN FULL SHOWERS 1-3 WEEKS
CHANGE TOWELS AND SHEETS DAILY
HAND WASHING
AVOID HEAT FRICTION
diagnositcs
f #15 scalpel for KOH ASSESS FOR PITYROSPORUM FOLLICULITIS /OR YEAST
Gram stain and culture of pus from carbuncles and abscesses are recommended, but treatment without these studies is reasonable in typical cases (idsa)
do not culture inflamed epidermoid cysts
sirs criteria
temperature >38°C or <36°C, tachypnea >24 breaths per minute, tachycardia >90 beats per minute, or white blood cell count >12 000 or <400 cells/µL
FFUC
NON PHARNM
look at the ssti pwerpoint
ALLOW SPONTANEOUS DRAINAGE,
PREVENT MEASURES LISTED
MOIST WARM COMPRESS
SHAVE GEL HYDRATE VEFORE SHAVING
Lipodermatosclerosis
Lipodermatosclerosis is a chronic inflammatory condition characterised by subcutaneous fibrosis and hardening of the skin on the lower legs.
Lipodermatosclerosis is also known as sclerosing panniculitis and hypodermitis sclerodermaformis.
Eikenella corrodens
HUMAN BITES AND CLOSED FIST INJURIES(cfi)
Depending on the location of infection, the treatment of choice is a combination of surgical management and antibiotics, such as ampicillin or penicillin. Antibiotics that are typically effective against oropharyngeal flora, such as clindamycin and metronidazole, are ineffective against Eikenella species.
https://www.pcds.org.uk/clinical-guidance/cellulitis-and-erysipelas
NON PURULENT SSTI
OFTEN ON FACE
ON UPPER DERMIS ( PAPILLARY ) AND LYMPHATICS
FACE EARS LOWER EXTREMITIES
SWOLLEN
ORANGE PEEL LOOK
CHILDREN
GERIATRIC
IMMUNE
HIV
EXPOSURE TO ORGANISMS
ALTERATION IN SKIN INTEGRIITY 2/2
TRAUMA
ATOPIC DERMATITIS
ALLERGIC CONTACT DERMATITIS
POSRIASIS
INSECT BITE
EDEMA
CLINICAL FINDINGS
ERYTHEMA WITH WELL DEMARCATED BORDERS OF INFLAMMATION
LYMPHATIC STREAKING MAY OCCUR
USU STUFF
UNILATERAL
PRURITUS
NEC FAS
DVT
DIAGNOSITCS
VBASED ON CLINICAL PRESENTATION
CULTURES RARELY HELPFUL
IMAGING FOR R/O NEC FASC
PYOMYOSITIS AND ABCESS
LABS
CBC ESR CRP
PHARM MGT
PCN V 500 MG QID X 10 DAYS
PCN ALLERGY MACROLIDE
PAIN MGT
IBUPROFEN
TYLENOL
REFER
ID OR SURGERY
RAPID PROGRESSION INFECTION
SIRS
IMMUNOCOMP
NECROTIZING INFECTIONS
AGGRESSIVE SOFT TISSUE LESION
CAUSES NECROSIS MUSCLE FASCIA AND SC TISSUE
INTRODUCED VIA BREAK IN SKIN
OVERLYING TISSUE MAY NOT BE INVOLVEED AND THIS MAY CAUSE DELAY IN TREATMENT
GABHS
STAPH MSSA AND MRSA
HEMOPHILUS INFLUENZA - KIDS
SAME AS ERISYPELAS
ALCOHOLISM
ERYTHEMA
WARMTH
EXCRUCIATING PAIN DISPROPORTIONATE TO WOUND
FEVER >102
TACHYCARDIA
CREPITUS
SKIN BULLAE NECROSIS OR ECCHYMOSIS
THIN FOUL SMELLING DISCHARGE
BLOOD CULTURES IF RAPID PROGRESSION OF MANIFESTATIONS
NON PRAPID
BLOODCULTURES
URGENT SURGICAL EXPLORATION FOR AEROBIC AND ANAEROBIC GRAM STAIN CULTURE AND PATHOLOGY
AGGRESSIVE SX DEBRIDEMENT
IF NOT URGENT
CT
SSTI
GERIATRIC CONSIDERATIONS
EPIDERMAL /DERMAL JUNCTION FLATTENING
DECREASED BLOOD FLOW
IMMUNOSENESCENCE
2-3 FOLD MORTALITY IN SSTI ELDERLY
WOODS LAMP COLOR
BLUE HEALTHY SKIN
LIGHT PURPLE DEHYDRATION
WHITE VITILIGO
RED CORAL CORYNEBACTERIUM MINUTIISSIMUM
YELLOW-GREEN IS PATHOGENIC PSEUDOMONAS
GOUT
OM
GAS GANGRENE
ABSCESS
EPIDIYMITIS
THROMBOPHLEBITIS
CELLULITIS , ERISYPELAS
ERISYPELAS MORE DEMARCAED AND SUPERFICIAL AND CAN BE ON FACE
PRESENCE OF HEMORRHAGIC BULLAE OR LYMPHANGITIS SUGGEST
STREPTOCOCCAL INFECTION AS OPPOSED TO STAPHYLOCOCCAL INFECTION
CELLULITIS ERISYPELAS COMPLICATIONS
YMPHANGITIS SPREADS PROXIMALLY
DEEP SEATED INFECTION EG FASCIITIS, MYOSITIS
SEPTICEMIA
NEPHRITIS
CELLULITIS TREATMENT
FLUCLOXACILLIN 500 MG 4 X DAY X 7-10 DAYS -BACTERICIDAL ON STREP AND STAPH CHECK IF PCN V
PCN ALLERGY DOXYCYCLINE- SE POWERPOINT
ERYTHRASMA
LESIONS ARE SCALING FISSURING/WRINKLING BROWNISH MACERATED
TOES MOST BETWEEN 3RD AND 4TH TOES AND WHITISH COLOR
RESEMBLES TINEA
ERYTHRASMA IS OFTEN 2/2 TINEA PEDIS
WARM HUMID CLIMATE
ELDERLY +IMMUNOCOMPROMISED
ERYTHRASMA TREATMENT
FIRST LINE
TOPICAL
BENZOYL PEROCIDES WASH AND 5% GEL
CLINDAMYCIN 2% OR AZOLE CREAMS BID FOR 2 WEEKS
WIDESPREAD ERYTHRASMA
TOPICAL ABX+ TOPICAL
SUSCEPTIBEL TO PCS,IST GEN CEPHALOSPORINS, MYCINS9MACROLIDES
ORAL ERYTHROMYCIN 500MG BID x14 DAYS IS DRUG OF CHOICE
RELAPSES -ORAL TETRACYCLINE 250 MG PO QID X 14 DAYS- NOT PFR PREGNANT WOMEN
COMMON RELAPSES 6-12 MONTHS QUIZLET
RED LEIGHT THERAPY ALTERNATIVE ADJUNCT - LITTLE CLIINICAL DATA TO SUPPORT
PATIENT EDUCATION ERYTHRASMA
EDUCATE ENTIRE FAMILY IN REDUCING RISK OF REPEAT INFECTIONS MINIMISE COLONIZATION
PROPER CLOTHES WASHING
REPLACE SHOES FREQUENTLY
ANTIBACTERIAL WASHES
LOOSE FITTING WICKING CLOTHING
AVOID HUMIDITY
ALUMINUM CHLORIDE DEODOARNAT TO FEET ANECDOTAL
ERYTHRAASMA
• Wood light examination
• Potassium hydroxide preparation
• Gram-stain
• Culture
DIFF
(1) acanthosis nigricans,
(2) allergic contact dermatitis,
(3) cutaneous candidiasis, and
(4) intertrigo.
TINEA PEDIS AND OTHER TINEA-CRURIS,
TINEA PEDIS
T RUBRUM MOST COMMON
T METAGRAPHYTES
EPIDEROPHYTON FLOCCOSUM
CLOSE CONTACT ANIMALS
WARM CLIMATES
SPORTS
IMMUNOCOMPROMISED/STEROID USE
TINEA
WELL CIRCUMSCRIBBED
RED SCALY OFTEN ROUND
ARCHIFORM
PRURITIC
DIAGNOSIS
KOH SCRAPING
WOODS LAMP
CLOTRIMAZOLE BID
MICONAZOLE OD TO BID
ECONAZOLE
KETOCONAZOLE OD
NAFTIDINE
TERBINAFINE -LAMISIL OD TO BID
JUBLIA
2 WEEKS TREATMENT
ANOTHER SLIDE SAYS 6 WEEKS TREATMENT FOR TINEAPEDIS, 2 WEEKS FOR CANDIDAISIS
ONCHOMYCOSIS RISK FACTORS
TINEA UNGUIUM/ONCHOMYCOSIS
DIABETES
ONCHYOMYCOSIS
APPEARANCE
KOH PREP
CULTURE
PERIODIC ACIDD-SCHIFF PAS
ONCHOMYCOSIS TREATMENT
CUTLURE CONFIRMS TINEA UNGUIUM
0-50% NAIL TOPICAL
EFINACONAZOLE -JUBLIA 10% DAILY X 48 WEEKS
CICLOPIROX- PENLAC 8% X 48 WEEKS DONT DC IF CLEARS UP,NEW NAIL MAY SHOW CLEARANCE
>50% INVOLVEMENT , PROXIMAL AND LATERAL
ORAL
TERBANIFINE 250 MG X 6-12 WEEKS
ITRACONAZOLE 200 MG PULSE OR CONTINUOUS RX
NAIL REMOVAL
TERBAINFINE HEPATO AND RENAL TOXICITY- LFT Q 6 WEEKS IF NAUSEA AND ANOREXIA
KETOCONAZOLE PO HEPATOTOXICITY DRUG INTERACTIONS
ITRACONAZOLE CYP 50 SYSTEM CYP3A4- DRUG DRUG INTERACTIONS
TINEA CAPITIS ALSO KNOWNN AS HERPES TONSURAS
RINGWORM
MICROSPORUM
TRICHOPHYTON
FFUNGUS GROWS DOWNWARDS IN STRATUM CORNEUM AND INVADES KERATIN
INFECTED HAIR BECOMES BRITTLE AND BREAKS
INFLAMMATORY AND NON INFLAMMATORY TYPES
CAN DEVELOP KERION - OOZING ABSCESS
CONTAGION
HUMANS
ANIMALS
SOIL
SHARING BRUSHES HATS
COMMON AFRICA AND SOUTH AMERICA
TINEA CAPITIS
GREEN FLUORESCENCE HAIRS WOODS LAMP
DOES NOT ALWAYS SHOW DUE TO INFLAMMATION
KOH OR CULTURE HAIR SHAFTS,
NIH SHAYS SCHIFF TEST- WILL ALSO SHOW GRANULOMATOUS AND NEUTROPHILLIC
TOPICAL ALONE IS NOT ENOUGH
ORAL AND TOPICAL
TOPICAL USE FOR FIRST TWO WEEKS
1% OR 2.5% SELENIUM SHAMPOO
2% MICONAZOLE
TERBINAFINE-UP TO 6 WEEKS
FLUCONAZOLE UP TO 6 WEEKS
NIH -GRISEOFULVIN
SHOULD HAVEE NEGATIVE CUTLURE FOLLOW UP
FAMILY EDUCATION
TREAT /CHECKFAMILY
PILLOWS LINENS CLEANSE OR CHANGE
NOT SHARE BRUSHES HATS
GENERAL TINEA TREATMENT DURATION
T CORPORIS /CRURIS TOPICAL AF X 2 WEEKS
T PEDIS TOPICAL AF X 6 WEEKS OR MORE
T CAPITIS PO X 6 WEEKS OR MORE
AF SHAMPOO FOR FIRST 2 WEEKS
ONCHOMYCOSIS 48 WEEKS FOR TOPICAL
PROXIMAL SUBUNGAL ORAL ANTIFUNGALS 6-12 WEEKS
tineas
follow up
education
hygiene
shoes etc
oral therapy lft at baseline , 2 weeks then 6 weeks and prn
recheck pt prn for topical therapy
no resolution - refer to DERMATOLOGY
geritrics
BENIGN LESIONS
COMMON IN ELDERLY
CAN BE CONFUSED WITH SKIN CANCERS
SOLAR LENTIGO -LIVER OR AGE SPOTS-ARES OF FMELANIN OVERPRODUCTION
PICTURE
SENILE PUERPERA
HEMORRHAGE IN PAPILLARY DERMIS
ON SUN EXPOSED AREAS- SKIN AND VESSELS MORE BRITTLE
ANTICOAG THERAPY
LEAVE BRONZE DISCOLORATION
SEBORRHEIC KERATOSES
BENIGN CAN BE REMOVED BY CRYOTHERAPY CURETTAGE
OR SHAVE INCISION
SUDDEN ERUPTION OF MULTIPLE CAN MEAN INTERNAL MALIGNANCY
HERPES VIRAL CULTURE
IMPETIGO AND ECTHYMA
Impetigo is a superficial skin infection with crusting or bullae caused by streptococci, staphylococci, or both.
non bullous -clusters of vesicels or pustules with honey colored crust exudate
bullous -vesicles enlarge rapidly to become bullous
Ecthyma is an ulcerative form of impetigo. Diagnosis is clinical. Treatment is with topical and sometimes oral antibiotics
i & E
risk factors
moist envrionment
poor hygiene
chronic nasopharyngeal carriage of staph or streptococci
staph predominant
mrsa common
i&E
clinical evaluation
cultures only when not responding to empiric therapy
GRAM STAIN C&S
nasal culture with recurrent
ESR
pharm
topical limited lesions
topical mupirocin ointment 3 x day for 7 days
retapamulin 2 x day for 5 days
oral therapy for 7 day regimen w agent effective against staph aureus (IDSA) unless cultures yield streptococci alone (when oral penicillin is the recommended agent)
oral abx dicloxacillin 250 qid x 7 days
cephalexin 250-500 mg qid x 10 days
AZITHROMYCIN DOSE PACK
AUGMENTIN
(erythromycin 250 mg qid po)
no empiric therapy against mrsa withou culture
idsa
MRSA doxycycline /clindamycin/smxtmp
SOAK CRUSTS WITH WET COMPRESSES TO REMOVE CRUSTS
ALLOWS PENETRATION OF TOPICAL ABX
DAILY WASHING WITH HIBICLENS
I & E
DIFFS
ECTHYMA
ERISYPELAS
HESV
IRRITANT
IRRITANT DERMATITIS
LOCATION : USU HANDS
IRRITANTS: SOLVENTS , BLEACH , ALCOHOL, CHEMICALS
SYMPTOMS: BURNING PRURITIS PAIN
APPEARANCE: DRY FISSURED SKIN
LESION BORDERS: INDISTINCT
ALLERIGC
LOCATION: EXPOSED AREAS USU HANDS
CAUSE: NICKEL JEWELRY
MEDICATIONS POISON OAK OR IVY, OTHER PRODUCTS
SYMPTOMS:PRURITUS
APPEARANCE: VESICLES AND BULLAE
LESION BORDERS DISTINCT ANGLES LINE AND BORDERS
?IRRITANT CONTACT DERMATITIS
THOROUGH HISTORY
USU NO TESTS NECESSARY. ONLY IF SECONDARY INFECTION SUSPECTED
KOH
PATCH TEST TO IDENTIFY ALLERGEN -DERMATOLOGIST
DIFF DIAGNOSES
MYCOSIS FUNGOIDES
SCABIES
PSORIASIS
SEBORRHEIC DERMATITIS
C DERMATITIS
MGT NON PHARM
REMOVE ALLERGEN /IRRITANT
PREVENT SECONDARY INFECTION
SYMPTOM MGT
NO SCRATCHING
CD
CALAMINE LOTION OR OATMEAL BATHS
BENADRYL 25-50 MG PO
MILD CASES HYDROCORTISONE CREAM NON RX STRENGTH 0.1 %
MID OR HIGH POTENCY
TRIAMCINOLONE 0.1 %
CLOBETASOL (HIGH) 0.05%
BARRIER CREAM - ZINC OXIDE -PROTECT SKIN AND RETAIN MOISTURE
CD PHARM
TOPICAL CCS OR PO IM CCS
TOPICAL _ SEVERE ITCHING , RASH DOES NOT IMPROVE 2-3 DAYS USE TOP CCS
PO
IF REACTION COVERS LARGE PORTION OF SKIN 20%, PERIORBITAL , GENITAL OR IS SEVERE
5-7 DAYS OF STEROID 0.5- 1 MG/KG /DAY , HALVE DOSE FOR NEXT 5-7 DAYS
ANTIHISTAMINES
BUTTARO
SKIN A&P
EPIDERMIS AVASCULAR-OUTER HORNY LAYER CORNEUM ,INNER HORNY LAYER MUCOSUM, KERATINOCYTES SHED SLOUGH OFF AS SQUAMES
STRATUM CORNEUM PROTECTS AGAINT BACTERIA
INNER LAYER CONTAINS LANGERHANS CELLS -ANTIGEN PRESENTING CELLS-ALLERGIC SKIN RESPONSE AND THEY MIGRATE TO LYMPH NODES
MELANOCYTES IN BASAL EPIDERMIS PROTECT AGAINST UV
DERMIS
ECCRINE APOCRINE SEBACEOUS GLANDS FOLLICLES ETC -BLOOD SUPPLY NERVES LYMPH
EARS DERMIS HAS CERUMEN PRODUCING GLANDS
HYPODERMIS OR SUBCUTIS FAT, INSULATION, CUSHION FROM INJURY AND
The papillary dermis is the superficial layer, lying deep to the epidermis. The papillary dermis is composed of loose connective tissue that is highly vascular. The reticular layer is the deep layer, forming a thick layer of dense connective tissue that constitutes the bulk of the dermis.
SKIN
HISTORY TAKING
OLDCARTS
PRIOR SKIN DISORDER
MEDICATIONS,OTC SCRIPT AND HERBAL, NUTRITIONAL SUPPLEMENTS
TRAVEL
SOCIAL AND OCCUPATIONAL
SELF CARE PRACTICES -LOTIONS SKIN CARE,SOAPS LLUANDRY PRODUCTS/CHANGE
FAMILY HISTORY OF ALLERGY ATOPY EXZEMA OR ASTHMA IN CHILDHOOD
DIAGNOSTIC TOOLS
CONTACT DERMATOSCOPE
OR NON CONTACT MICROSCOPE-MELANOMA
OBLIQUE LIGHT ILLUMINATE AND CONTRAST
PEN LIGHT -SYST OR PUS
WOOD LAMP -EMITS LONG WAVELENGTHS OF UV RAYS THROUGH A FILTER (>365NM) HARMLESS SHOWS ERYTHRASMA (CORNNYEBACTERIUM CORAL RED) TINEA VERSICOLOR( WHITE YELLOW), VITILIGO ( WHITE)PSEUDOMONAS PALE BLUE, DERMATOPHYTES YELLOW
DERMATOFIBROMA DEEP EXCISIION NEEDED
SIGN
FITZPATRICK SIGN
URTICARIA
DERMATOGRAPHISM
FITZ PARICK - SQUEEZE SIDES AND IT INDENTS
DERMATOGRAPHISM- URTICARIA PT , RUB BACK OF FINGERNAIL -HISTAMINE RELEASED AREA BECOMES RED AND RAISED
SKIN LESION
DESCRIPTION
DISTRIBUTION/LOCATION
SIZE
SHAPE
COLOR
BORDERS
SURFACE CHARACTERISTICS
TESTS
DIASCOPY
USE FLAT MICROSCOPE SLIDE OR MAGNIFYING GLASS, PRESSS ON BLUE RED LESION.BLANCH FOLLOWED BY REFILL IS BLOOD IN CAPILLARIES
NO BLANCHING IS BLOOD LEACHING OUTSIDE OF CAPILLARIES EG PETECHIAE
GRAM STAIN EXUDATE - GRAM POS OR NEG
TZANCK TEST- GIANT CELLS COMMON IN HSV VZV UNROOF FRESH VESICLE
KOH -HYPHAE AND SPORES CANDIDIASIS , OR SPAGHETTI AND MEATBALLS OF TINEA VERSICOLOR ( MALASEZIA)
SUPERFICIAL SKIN SHAVING FROM TOP OF BURROW , OIL SOLUTION OR KOH SOLUTION
OFFICE PROCEDURES
READ BUTTARO CHAPTER
PRINCIPLES OF DERMATOLOGY WOUND HEALING
MOIST WEEPING LESIONS-BUROWS SOLUTION DRIES UP AND SOOTHES
EXUDATIVE SKIN DISEASES-WET DRESSINGS -REDUCE INFLAMMTION BY VASOCONTRICTION, PROMOTE DRYING OF LESIONS AND WOUND DEBRIDEMENT
DRY DERMATITIS
OINTMENTS
THEN CREAMS
THEN LOTIONS
THERAPEUTIC AGENTS IN OINTMENTS OR CREAMS
DONT SOAP TOO MUCH OR SHOWER TOO MUCH
PETROLATUM BIG FAVORITE BIOPSY SITES SKIN FISSURES AND IRRITATED SKIN
MEDS TOPICAL ,INTRALESIONAL, SYSTEMIC
LESIONS RX BIOPSY SURGERY ELECTROCAUTERY OR CRYOTHERAPY
TCC
MAINSTAY OF DERMATOLOGY CARE
REDUCE INFLAMMATORY RESPONSE
VASOCONSTRICTION
DECREASE IN COLLAGEN SYNTHESIS
NEVER USE CLASS 1-IV ON FACE OR GENITALS
CLASS 1 SUPER POTENT
CLOBETASOL PROPRIONATE 0.05%
BETAMETHASONE DIPROPRIONATE ( DIPROLENE) 0.05% OINTMENT
FLUOCINOCIDE 0.1% CREAM
CL 2 POTENT
ELOCON0.1% OINTMENT
DIPROLENE CREAM 0.05%
CL 3 UPPER MIDSTRENGTH
FKUTICASONE PROPRIONATE 0.005% OINTMENT
BETAMETHASONE VALEARATE 0.1% OINTMENT
CLASS 4 MID STRENGTH
TRIAMCINOLONE 0.1% OINTMENT/CREAM (KENALOG)
ELOCON CREAM 0.1%
CLASS 5 LOWER MID STRENGTH
FLUOCINONIDE ACETONIDE 0.025% CREAM
HYDROCORTISONE VALEARATE ( WESTCORT) 0.2 % OINTMENT
CLASS 6 MILD
DESONIDE 0.5% OINTMENT CREAM LOTION
ACLOVATE 0.05% OINT.CREAM
LEAST POTENT
HYDROCORTISONE 2.5% ,1 % , 0.5 % OIN.CRE/LOTION
TCS S/E
COMMON WITH TCS OR THEIR VEHICLES :
ACNE LIKE ERUPTIONS
HYPOPIGMENTATION
TOO STRONG TOO LONG AFFECTS COLLAGEN SYNTHESIS - STRIAE AND ATROPHY
TELANGIECTASIA AND PUERPERA FROM SKIN THINNING
INFLAMMATION DOWN, STOP TREATMENT, CHANGE TO LESS POTENT AGENT, OR USE INTERMITTENT RX
IF LESION WORSENS CONSIDER FUNGAL OR YEAST INFECTION
HAIRY AREAS USE FOAM SPRAY OR GEL ABSORPTION'
VEHICLES ARE BASE OF ACTIVE INGREDIENTS -CREAMS SEMISOLID EMULSIONS OF OIL IN WATER
OINTMENT IS OIL -OCCLUSIVE ENHANCE DRUG ABSORPTION
ALWAYS USE THIN LAYER
1 GM COVERS AN AREA OF 10X 10 CM
SYSTEMIC CCS
CAUSE FLARE IN PSORIASIS
AVOID DUE TO S/E
SHORT TERM TREATMENT OF SELF LIIMITED RASHES ONLY
ANTIFUNGAL MEDICATION
CONTINUE PRODUCT ONE WEEK AFTER CLEARING LESION TO PREVENT RECURRENCE
TINEAS OFTEN RECUR THOUGH
SYSTEMIC ONLY FOR WIDESPREAD TINEA OR INFECTIONS THAT INVOLVE SCALP NAILS
AVOID ORAL KETOCONAZOLE HEPATOTOXICITY
TERBINAFINE NOT RECOMMENDED IF RENAL OR LIVER DX0LFFTS Q 6 WEEKS,NEUTROPENIA WITH TERBINAFINE
CREAMS POWDERS ORAL SUSPENSION,INTRAVAGINAL FOR CANDIDIASIS TABLETS LAST
ANTIVIRAL MEDICATION
ACYCLOVIR , FAMCICLOVIR VALACYLCLVIR FOR HERPETIC
CAN USE TOPICAL PENCICLOVIR ORAL HSV OR ABREVA
ACUTE FOR ORAL AV, SUPPRESS DX
SUPPRESSIVE THERAPY FOR >6 X YEAR OUTBREAKS
BIOLOGICS
TNF ANTAGONISTS
BIOLOGICS/MABS
MODERATE TO SEVERE PSORIASIS
INFLIXIMAB
ETANEREPT
ADALIMUMAB
CAN BE USED FOR PSORIATIC ARTHRITIS-PRESCRIBED BY RHEUMATOLOGY OR DERMATOLOGY-SQ IM OR IVI
CAN INCREASE RISK OF LYMPHOMA, FUNGI VIRUSES MYCOBACTERIA APLASTIC ANEMIA MELANOMA AND OTHER SKIN CANCERS
PT IMMUNE STATUS AND VACCINES BEFORE STARTING MABS
SKIN CANCERS ETIOLOGY AND RISK FACTORS
5.4 million cases of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are diagnosed each year, occurring in about 3.3 million Americans, as some people have more than one.
BASAL MOST COMMON , MELANOMA MOST FATAL
90% OF ALL SKIN CANCERS RELATED TO THE SUN
FAIR BLUE EYES
BLONDE
FRECKLES
FAM HX
SUN EXPOSURE
HISTORY OF SUNBURN
PIGMENTED LESIONS
SIGNS OF MALIGNANCY
SUDDEN DARKENING ># TUMOR CELLS
SPREAD OF COLOR -TUMOR CELLS MIGRATING AT DIFFERENCT SPEEDS AND DIRECTIONS ( HORIZONTAL GROWTH)
RED - VASODILATION AND INFLAMMTION
BLUE - DEEPER TUMOR
WHITE INFLAMMATION OR REGRESSION
BORDER
IRREGULAR BORDERS -MIGRATION
SATELLITE PIGMENTATION -MIGRATING BEYOND CONFINES OF TUMOR
DEPIGMENTED HALO - DESTRUCTION OF MELANOCYTES ? IMMUNE? INFLAMATION
CHARACTER
SCALY
EROSION'
OOZING CRUSTING
BLEEDING
ULCERATION
SYMPTOMS
TENDERNESS
PE
TBSE INCLUDING PALMS AND SOLES,NAILS
SCALP
SUSPICIOUS LESION WARRANTS BIOPSY/REFERRAL
SKIN CANCER 3 MAIN TYPES
BASAL
PEARLY BORDERS
RAISED SHINY
DEVELOP TELANGIECTASES
ADVANCED HAVE CENTRAL ULCERATION AND CRUSTING
80% OF NON MALIGNANT CANCERS
RARE TO METASTASIZE OR MORTALITY
SUN EXPOSED AREAS AS ADOLESCENT/CHILD,USU HEAD NECK ESP NOSE
TREATMENT - COMSETIC
AAL TYPES
SCC
20 % SKIN CANCERS
ACTINIC KERATOSES ARE PRE SCC
ROUGH
SUN EXPOSED AREAS STRONG COLRRELATION WITH UV
BLEEDS EASILY
HEAPED UP APPEARANCE FROM KERATINIZATION
METASTATIC RATE 3-10%
MELANOMA
OCCURS IN NAILS HANDS FEET OF BLACKS, BLACK SKINNED ASIANS
WHITES-BACK ANTERIOR LOWER LEGS
A ASYMMETRY
B BORDER IRREGULAR
C COLOR VARIABILITY
D DIAMETER >6MM
E ELEVATION
4% SKIIN CNACERS, 65% DEATH FROM SKIN CANCER
5 YEAR SURVIVAL RATE INVERSELY PROPORTIONAL TO DEPTH OF MELANOMA AT DIAGNOSIS
ACRAL LENTIGINOUS MELANOMA
ABCDE
SKIIN CANCER SCREENING
USPSTF
INSUFFI EVIDENCE TO RECOMMEND FOR/AGAINST FULL BODY SCREENING
HCPROVIDER BE AWARE OF SKIN LESIONS WHEN PERFORMING PE
ANNUAL SCREENING FOR PTS WITH HISTORY OF SKIN CANCER
AMERICAN CANCER SOCIETY:
EVERY 3 YEARS 20-40 AND ANNUAL OVER 40 -WITH DERMATOLOGIST
SKIN CANCERS
EXPOSURE TO UV
FAIR, BLONDE OR RED HEAD
LIGHT BLUE OR GREEN EYES
BLISTERING SUNBURN ADOLESCENT
IMMMUNOCOMPROMISED
VERY HIGH RISK
TANNING DEVICES -INCREASE SCC2.5 FOLD
2 FIRST DEGREE RELATIVES WITH MELANOMA, 100 NEVI OR 5+ ATYPICAL NEVI
250 + TREATMENTS + UVV FOR PSORIASIS
RAD THERAPY AS CHILD
SC
SKIN BIOPSY
SHAVE OR PUNCH OR EXCISIONAL
SC DIFF DIAGNOSES
EACH OTHER
ACTINIC KERATOSIS-PRECNCEROUS TREAT WITH LIQUID NITROGEN
SEBORRHEIC KERATOSIS
SC TREATMENT
BIOSPY EXCISIONA;
BCC ELECTRODESSICATION AND CURRETAGE
SCC TOTAL EXCISION
MM WIDE EXCISION OR MOHS
ANNUAL SKIN EXAM
ALL DIAGNOSTIC EXAMS - EXPERIENCED PROVIDER
REFER TO DERMATOLOGY FOR ALL SUSPICIOUS LESIONS
ACTININC KERATOSIS CAUSE , PE , DX, OUTCOME
PRE CANCEROUS
ELDERLY, FAIR SKINNED SUN SENSITIVE
ROUGH SCALY SAND PAPERY, AREAS OF SUN EXPOSURE
FACE
NECK
EARS
FOREARMS
FELT BEFORE SEEN, SANDPAPER TEXTURE
DIAGNOSIS ON PRESEENATION
BIOPSY FOR LESIONS -LOOKK LIKE SCC OR UNRESPONSIVE TO RX
20% DEVELOP INTO SCC
ACTINIC KERA
REFER TO DERM
LESIONS MAY REGRESS , STAY OR PROGRESS TO SCC-UNREDICATBALE
GOAL OF TREATMENT
COMPLETE ERADICATION-LIMIT PERI DAMAGE
MEDICAL
5 FU TOPICAL CREAM 5% BD X 1 MONTH
LESIONS BECOME ERYHTHEMATOUS AND HURT,ULCER AND CURST
HEAL WITHIN 2 WEEKS OF END OF TREATMENT
IMIQUIMOD TOPICAL CREAM 2-3 X DAY FOR 1 - 4 MONTHS
PHOTODYNAMIC THERAPY
ADNEXA DISEASE
ADNEXA = BIND TO, ATTACH
DERMATOLOGY IS PILOSEBACEOUS UNIT -HAIR FOLLICLE,, SEBACEOUS, ECCRINE APOCRIEN ARRECTOR PILI MUSCLE
EG SKIN HAIR NAILS
ACNE VULGARIS
MOST COMMON DERM DISORDER IN US
DISORDER OF PILOSEBACEOUS FOLLICLES W >SEBUM PRODUCTION ALTERED KERATINIZATION, INFLAMMATION AND BACTERIAL COLONIZATION
BLACKS MORE PRONE TO POSTINFLAMMATORY HYPERPIGMENTATION
PATHO
INFLAMMATORY MEDIATORS
ABNORMAL DESQUAMATION OF KERATINOCYTES THAT PLUG THE PILOSEBACEOUS FOLLICLES
> SEBUM PRODUCTION
COLONIZE WITH PROPRIONIBACTERIUM ACNES
FACE NECK UPPER TRUNK
BLACK COMEDONES ARE OPEN FOLLICLE CELL BUILD UP
WHITE COMEDONES ARE CLOSED DD-CYSTIC SWELLING PRIOR TO BEING A PUSTULE OR PAPULE
ACNE
CLINICAL EXAM
IF FANDROGEN THOUGHT TO BE PROBLEM THEN:
TOTAL TESTOSTERONE
DHEAS
LH
FSH
LIPID PROFILE
GLUCOSE TOLERANCE TESTING???
MILIA
SEBACEOUS HYPERPLASIA
DILATED PORE OF WINER ( THAT GREAT BIG BLACKHEAD)
and Favre–Racouchot syndrome LOTS OF TINY BLACKHEADS OLD MEN
MOLLUSCUM
PSUEDOFOLLICULITIS BARBAE
TOPICAL FIRST
RETINOIDS
TRETINOIN RETIN A
BENZOYL PEROXIDE
AZELEX
SALICYLIC ACID
TOPICAL ABX FOR THE P ACNES
ERYTHROMYCIN, CLINDAMYCIN, METRONIDAZOLE, NOT MONOTHERAPY
USE DWITH OTHERR TOPICALS RETINS
ORAL ABX
BENZOYL PEROXIDE ( TO REDUCE RESISTANCE)AND ERYTHROMYCIN FOR 6-8 WEEKS UP TO MONTHS
HORMONE THEAPY
ANDROGENS INDUCE ACNE
USE OCS SPIRONOLACTONE, AND DROSPIRENONE
ISOTRETINOIN - PRESCRIBED BY DERM
4-6 MONTHS
MONTHLY TRIGLYCERIDE LEVELS AND LIVER FUNCTION TESTS
TERATOGENIC
ACNE TREATMENT TAKES WEEKS TO MONTHS TO WORK - WARN THE PATINET
ROSACEA
OCULAR ROSACEA = IMMEDIATE REFERRAL TO OPTHALMOLOGIST
OFTEN COEXISTS WITH ACEN VULGARIS AND MAY MIMIC IT
AGE 30-50
WOMEN>MEN
PRIMARY DISTINCTION IS NO COMEDONES IN ROSACEA
NO CURE
TRETMENT TAKES WEEKS TO MONTHS
PATH
>SEBUM PRODUCTION
HYPERPROLIFERATION OF KERATINOCYTES, W INFLAMMATION, AND COLONISE P ACNE
FACIAL FLUSHING IS EARLY SIGN ,PROGRESSES LATER CANBE PERMANENT
FLUSH W HEAT ALCOHOL SPICY FOODS EMOTION
PRESENTATION
FLUSHING
FACIAL ERYTHEMA
INFLAMMATORY PAP AND PUSTULES
TELANGIECTASISA
WATERY IRRITATED EYES
TREATMENT ROSACEA
NO DIAGNOSTICS
MAY DO ANA TO R/O LUPUS ERYTHEMATOSUS
PRIMARY
METRONIDAZOLE 1 % OR 0.75% GEL BID 3-4 MONTHS
AZELAIC ACID TOPICAL BID 2 MONTHS
PLEXION CLEANSER OR SULFACETAMIDE/SULFUR
TETRACYCLINE 250-500 BID OR DOXY 100-200 MG FOR 3 MONTHS
NOT RESPONSIVE TO TOPICAL OR ORAL ABX , REFER TO DERM
OCULAR FORM V SERIOUS
HYPERHIDROSIS
ETIOLOGY INCIDENCE FINDINGS
3 % POPULATION
EXCESSIVE SWEATING
ABNORMAL WETNESS
SWEATY PALMS
EXCESS AXILLARY SWEATING
GUSTATORY-STIMULATED SWEATING
WET SHOES
OFFENSIVE ODOR
dyshidrosis eczema
MILARIA RUBRA - FROM BLOCKED SWEAT GLANDS
IDIOPATHIC MAJORITY-SYMPATHETIC OVERSTIMULATION ECCRINE SWEAT GLANDS
2NDRY HYPERHIDROSIS IS MORE TREATABLE
LOOK FOR UNDERLYING CAUSES -PHEOCHROMOCYTOMA, DIABETES -HEAT INTOLERANCE IN UPPER HALF OF BODY AND NO SWEATING LOWER HALF IS DIABETIC PERIPHERAL AUTONOMIC NEUROPATHY
TSH R/O
THYROXINE R/O
FBG R/O DM
FSH R/O MENOPAUSE
LH R/O MENOPAUSE
IODINE STARCH TEST
URINARY CATECHOLAMINES ???
URIC ACID????
HIPERHYDROSIS
TPICAL 20% ALCOHOLIC SOLUTION OF ALUMINIUM CHLORIDE HEXAHYDRATE( DRYSOL, KERALYT)-BLOCK SWEAT DUCTS
XERAC FOR SENSITIVE SKIN
COMPLEX CARE WITH THIS, HAVE TO WEAR OCCLUSIVE WRAP
BOTOX INJECTIONS FEET, AXILLAE
THORACIC ENDOSCOPY TO INTERRUPT UPPER DORSAL SYMPATHETIC CHAIN OF D2 AND D3 CAN PROVIDE A CURE
animal bites and human bites
incidence
dog bites majority- cost one billion a year
800,000 yearly visits . wmost destructive bites
occur most on children
crush
soft tissue
neurovascular
death
cat bites second most commmon 15 %
puncture
6% hospitalizattions for infection
humans -includes cfi closed fist injury
human bite sinfection rates 10%
young child
sex
self inflicted - nail bites
fight bites
bites
risk factors for infection
>50 years
immunosuupressed (diabetic,advanced liver disese,asplenia)
crush , puncture , penetrates joint capsule or periosteum
location hand foot
failure to irrigate/debride initial management
treatment delay of >12 hours
edema at site
pvd
animal bites pathogens
usu bacterial
aerobic
pasteurella including multocida
strep
staphylococci
corynebacteriium
anaerobic
bacteroides
actinomyces
porphyromonas
fusobacterium
viral
rabies,usu bats raccoons skunks foxes
tetanus
HUMAN BITES PATHOGENS
STAPH ,MRSA
STREP
EIKENELLA CORRODENS -BIG IN CFI
CAN BE RESISTANT TO EMPIRIC ABX AND CAN PRODUCE BETA LACTAMASES-
GROWS FAST CAN LEAD TO ENDOCARIDTIS
HSPITALIZATION FOR HUMAN BITES ESP OF HAND -POLYFLORA SKIN TEETH
VIRAL
RARER HSV 1 HSV 2 HEP B HEP C
HIV EXTREMELY LOW
cdc link for exposure to bites/animals
https://www.cdc.gov/rabies/exposure/index.html
CLINCAL FINDINGS
LOCATION
TIME (PTS WAIT SEVEREAL DAYS)
SPECIES BEHVIOIR ANIMAL
DOMESTICATION
RABIES VACCINE STATUS
WAS ANIMAL PROVOKED
CURRENT MED LIST
PMH : EMPHASIS OM IMMUNOCOMPETENCE, SPLENECTOMY, VENOUS OR LYMPHATIC INSUFFIENCY
LIVER DX
HUMAN BITES
TEST BITER FOR INFECTIOUS DX
IS ANIMAL RABIES PRONE
LOCATION, DEPTH , EXTENT, TYPE OF WOUND
S/S INFECION, INCLUDING RED STREAKING
SIGNS OF COMPARTMENT SYNDROME,SIGNS OF TENDON JOINT NERVE INVOLVEMENT
COMPARTMENT SYNDROME
SIGNS
DISPROPORTIONATE PAIN
PARASTHESIAS
PALLOR
PARALYSIS
BITES
INFECTED WOUNDS
CBC,
CRP
AEROBIC AND ANAEROBIC CULTURES ( ANAEROBIC TRANSPORTER, NO FRIDGE,NOT FROM BOWEL OROPHARYNX, VAGINA,-AREAS OF NORMAL CIRCULATING ANAEROBES)
DEEP COMPLEX WOUNDS
X RAY STUDIES FOR BONE OR JOINT INVOLVEMENT
HEP B
HEP C
IRRIGATE WOUND VIGILANTLY WITH AT LEAST 150 MLS STERRILE SALINE, OR WARM TAP WATER IF NONE AVAILABLE
DEVITALIZED TISSUE, FOREIGN BODIES, CLOTS CAUTIOUSLY DEBRIDED
AGGRESSIVE IRRIGATION AND DRAINAGE, WOUND PACKING NECESSARY IF CULTURES REVEAL INFECTION
MOST WOUNDS DONT DEVELOP S/S INFECTION UNTIL 24- 7 2 HOURS AFTER BITE
FACE BITES
REFER TO ED /PLASTICS IMMEDICTELY, AFTER IRRIGATION AND PREEMPTIVE ABX
DONT ATTEMPT TO CLOSE BITES -LEVEOPEN ESPECIALLY HAND, DELAYED PRIMARY OR SECONDARY CLOSURE
HAND FOOT WOUNDS IMMOBILIZED AND ELEVATED FOR 1-3 DAYS
CLOSE OUTPATIENT FOLLOW UP
FRESH UNINFECTED WOUNDS CONTROVERSY OVER ABX
CAT OR HAND BITE - 5-7 DAYS PROPHYLAXIS
SOME RECOMMEND PROPHYLACTIC ABX ALL BITES THAT PRESENT AFTER 72 HOURS
FRSH
AUGMENTIN 500/125 TID X 5-7- DAYS
CLINDAMYCIN +DOXYCYCLINE OR BACTRIM FOR PCN ALLERGY ( CLINDAMYCIN INEFFECTIVE AGAINST PASTEURELLA
LEVOFLOXACIN OR CIPRO
MACROLIDES FOR PREGANT PATIENTS ALLERGIC TO BETA LACTAMASE
OLDER INFECTED BITES = HOSPITALIZATION/ID
CAN HAVE MRSA FROM ANIMAL BITES- HIGH PREVALENCE AREAS
TMP SMX , DOXY OR CLNIDAMYCIN
SEVERE LINEZOLID PODONT USE DICLOXACILLIN CEPHALEXIN ERYTHROMYICN EMPIRICALLY AS SOLE AGENTS, NOT EFFECTIVE AGAINST PASTEURELLA OR EIKENELLA
BOOSTERS/VIRAL
TDAP OR TD IF FULL PRIMARY TETANUS IMMUNIZATION ( CHILD) BUT NO BOOSTER IN 5 YEARS
NO FULL SERIES- NEED TETANUS IMMUNE GLOBULIN 250- 500 UNITS IM AS FIRST OF 3 MONTHLY DOSES
RABIES
LOCATION DEPENDENT
WASH WITH 1% IODINE OR SOAP AND WATER IMMEDIATELY-LOWERS RATE ALOT
ANIMAL IS ISOLATEDOR SACRIFICED FOR BRAIN EXAM
HEAD NECK INJURY POST EXPOSURE PROPHYLAXIS
CONSIDER POST EXPOOSURE PROPH IN BITES DISTANT PAST ( CAN OCCUR 8 YEARS LATER)
RABIES IMMUNE GLOBULIN-HRIG OR PCECV -HALF INJECTED AROUND SITE , HALF IM
IMMUNIZATION ALSO 1 ML HDCV OR PCECV IM DAYS 0.3,7,14
BITES REFERRAL
JOINT NERVE BONE TENDON COMPARTMENT SYNDROME -ORHTO
SIGNIFCANT HAND BITES- HAND SURGEON
EXTENSIVE FOR RECONSTRUCTION, PLASTICS
HEAD INJURIES -OTOLARNYGOLOGIC OR NEUROSURGERY
SIRS,SEVERE CELLULITIS AND BITES NOT HEALING- ID
PT EDUCATION
DNT HANDLE OR PROVOKE WILD ANIMALS
DONT PROVOKE DOMESTIC ANIMALS
RABIES VACCINE DOGS AND CATS MANDATROY IN US
LOOK FOR S/S RABIES- DROOLING FOAMING, FEARLESS, NERVOUS, AGGRESSIVE= RABIES
TEACH CHILDREN SAFE PET PLAY ,SUPERVISE CHILDREN
NEUTER PETS
ECZEMA
7 TYPES
ATOPIC
NEURODERMATITIS -KEEP SCRATCHING ,PLEASURE CENTER IN BRAIN
DYSHIDROTIC -HANDS AND TOES -IRRITANTS
SEBORRHEIC DERMATITIS -MALASEZZIA HAIR - NIZORAL ,HYDROCORTISONE FACE
STASIS DERMATITIS-( GRAVITATIONAL0-TOPICAL STEROID
NUMMULAR CHILDRENS, EXTREMITIES TRUNK, STEROID AND ABX IF OOZING ,CAN IIMITATE TINEA,TAKE SCRAPING ,USU STAPHAUREUS, MID-HIG POTENCY STEROID
HISTORY OF ASTHMA OR ALLERGIC RHINITIS
FLEXURAL INVOLVEMENT
HISTORY OF GENERALIZED DRY SKIN
ONSET OF RASH BEFORE TWO YEARS OF AGE
GOALS OF MANAGEMENT
ALLEVIATE PRURITUS
DECREASE DRYNESS AND INFLAMMATION
PREVENT INFECTION
TREATMENT NON PHARM
TEPID BATH/SOAK FOR FLARE UPS
NO VERY HOT WATER , LIMIT BATHING
SUPERFATTED SOAPS
EMOLLIENTS: EUCERIN, CETAPHIL, AQUAPHOR -GREASY, CERA VE
PHARM MGRT
ATARAX 25 MG TID, QID
BENADRYL 25-50 4-6HOURLY MAX 300 MG /24 HOURS
NON DROWSY
XYSAL
LORATADINE-CLARITIN
INFLAMMATION
TOPICAL STEROIDS
HYDROCORTISONE
FLUTICASONE PROPRIONATE CUTIVATE CREAM 0.05%
DC WHEN INFLAMMATION SUBSIDES , EMOLLIENT SHOULD BE CONTINUED
POTENCY DEPENDS ON LOCATION AND PRESENTATION
NON STEROIDAL CALCINEURIN INHIBITOR
INDICATORS:MOD-SEVERE ECZEMA, CONCERN OF TCS S/E
USE IS SHORT TERM INTERMITTENT
TACROLIMUS 0.03% AND 0.1%
pimecrolimus cream.ELIDEL 1%
MAINTENANCE 2/WEEK X 12 MONTHS
ATOPY
PPHARM TREATMENT CONTD
INTERMITTENT ATOPY 1-2 X ANNUAL
USE IM CCS OR OCS
TYPICAL DOSE PACK IS INSUFFICENT -USU REQUIRES 2-3 WEEKS
TAPER OCS 60/40/20 OVER 15-21 DAYS
FOLLOW UP AND PHARM RX
FF/U 2 WEEKS AND 6-8 WEEKS
IF SEVERE FLARE UP INCREASE POTENCY X 2 WEEKS
MOISTURIZE
AVOID/TREAT SECONDARY INFECTION
ECZEMA HERPETICUM
ECZEMA PATIENTS MORE PRONE TO HERPES, MOLLUSCUM WARTS
SERIOUS VIRAL COMPLICATION IS EH
PT USUALLY HAS UNDERLYING SKIN DISORDER USU AD AND DEVELOPS WIDESPREAD ERUPTION OF VESICLES AND EROSIONS WHEN EXPERIENCING PRIMARY HERPES OR HERPES REACTIVATION
DIAGNOSED WITH GIEMSA STAINED SCRAPING-MULTINUCLEATED GIANT CELLS- TZANK SMEAR I THINK
ORAL ANTIVIRAL EG VALTREX
PARONYCHIA
ETIOLOGY EPIDEMIOLOGY
CHRONIC INFLAMMATION TISSUE SURROUNDING NAIL
BACTERIAL OR FUNGAL
OR NON INFECTIOUS:
CHEMICAL IRRITANTS
WATER
hzv herpes zoxter
remember vzv is chickenpox
etoiology
vzv downregulates mhc and enables virus to evade immune response
prolonged incubation period
moves retrograde along sensory axons, establishes life long latency in regional ganglia ( reservoir)
reactivates -causes intense inflammation
and hemorrhagic necrosis of nerve endingss-typical neuropathic pain
neuronal loss of ganglion and fibrosis of afferent nerve fibers esp type c nociceptors
HZV
AGE
IMMUNE STATUS-ANTIVRALS USED FOR TRANSPLANT RECIPIENTS
BIOLOGICS INCREASED RISK OF HZVHIV
WOMEN
WHITES
TRANSMISSION
CAN TRANSMIT VZV TO VARICELLA NAIVE PTS
DISSEMINATED HZV IS AIRBORNE PRECAUTIONS
FINDINGS
ERYTHEMATOUS PAPULES
SINGLE DERMATOME
OR SEVERAL CONTIGUOUS DERMATOMES USU THORACIC AND LUMBAR, EYES - ANYWHERE
GROUPED VESICLES OR BULLAE AFTER FEW DAYS
3-4 DAYS LATER -PUSTULES
CAN BECOME HEMORRHAGIC
PRODROMAL PAIN PRECEDES RASH BY TWO TO THREE DAYS
COMP
POST HERPETIC NEURALGIA 90 DAYS UP TO YEAR 3/10 OR MORE
PARASTHESIAS PRURITUS ALLODYNIA IN AFFECTED DERMATOME
10-15% DEVELOP PHN
HERPES ZOSTER OPTHALMICUS
SIGHT THREATENING CONFDITION
PRODROME HEADACHE MALAISE FEVER
HYPERREMIC CONJUUNCTIVITS,EPISCLERITIS KERATITIS-STRONGEST FOR VISION LOSS
IF ON NOSE DEFINITE EYE INVOLVEMENT
ACUTE RETINAL NECROSIS
5TH CRANIAL NERVE
RAMSAY HUNT SYNDROME
IPSILATERAL FACIAL PARALYSIS EAR PAIN VESICLE IN AURICLE OR CANAL-8TH CRANIAL NERVE
OTHER RARER CONDITIONS
CLINICAL PRESENTATION
PCR ONLY IF UNSURE OF DIAGNOSIS
CAN DO PCR WITH CRUSTS EVEN, AND VITREOUS HUMOR
HIV TESTING IN AT RISK POPULATIONS
RECURRENT HZV RARER
WOMEN > MEN
TREATMENT PHARM
ANTIVIRALS
VALACYCLOVIR PRODRUG 1000 MG TID X 7 DAYS
FAMCICLOVIR PRODRUG 500 MD TID X 7 DAYS MORE EXPENSIVE
ACYCLOVIR LOWER BIOAVAILABLITY 800 MG 5 X DAY X 7 DAYS LOWER COMPLIANCE
BETTER RECOVERY WITHIN 72 HOURS FROM RASH ONSET
PREGNANCY
UPTODATE PREFERS ACYCLOVIR AS LONGEST HISTORY
ANALGESIA
CORTICOSTEROIDS
PREDNISONE 14-21 DAYS TAPER 40 MG AS START
NSAID
SHORT ACTING OPIODS OXYCODONE 5 MG (utd)
GABAPENTIN CANBE USED
LIDOCAINE 4% Q 6 HOURLY ( sHADOWHEALTH)
HZV NON PHARM
ISOLATE TILL CRUSTS OVER
WASH TOWELS SHEET
DONT SCRATCH AS HEAL
LOOSE FITTING COTTON CLOTHING
TICK BITES
ANAPLASMOSIS BLACKLEGGED ICK NORTH EAST REGION IXODES SCAPULARIS
BABESIOSIS PARAPSIES INFECTE RED BLOOD CELLS BABESIA MICROTI
THERE ARE OTHER TICK DISEASES NOT IN NORTHEAST
BORRELIA MAYONII MID WEST CAUSES LYME
BORELLIA BURGDORFEIR AND IXODES SCAPULARIS IN NE US CAUSE LYME DISEASE
LYME DISEASE
ERYTHEMA MIGRANS WITH CENTRAL CLEARING AND NECROTIC CENTER
BALCK LEGGED TICKS LYME IS A SPIROCHETE BACTERIA
HEADACHE
FATIGUE
REGIONAL LYMPHADENOPATHY
SKIN RASH ERYTHEMA MIGRANS 80% OF PATEITNS
UNTREATED SPREADS TO JOINTS HEART AND NERVOUS SYSTEM
IMPACTED BY PREVIOUS INFECTION
TRADITIONAL:
ELISA TEST,- IGM + IGG ,MAY BE CROSS REACTIONS , FALSE + IGM MORE COMMON IF POSITIVE THEN WESTERN BLOT ASSAY
WESTERN BLOT ASSAY HAS SEPARATE IGM AND IGG BLOTS
IGM + IF 2 OR 3 BANDS DETECTED
IGG + IF 5 OR 10 BANDS DETECTED
WESTERN BLOT GM PRONE TO FALSE POSITIVES (UTD)
LYME TREATMENT
SOMETIMES PROPHYLAXIS AFTER TICK BITE
SINGLE EM JIS TREATED DIFFERENTLY TO MULTIPLE E/ MIGRANS WHICH IS EARLY DISSEMINATED DISEASE
ALL PTS WITH EM SHOUED BE TREATED EARLY
1.DOXYCYCLINE100 MG PO BID X 10 DAYS
AMOXICILLIN 500 MG PO TID X 14 DAYS
CEFUROXIME 500 MG BID x 14 DAYS
MRSA TREATMENT
B
D
BACTRIM
DOXYCYLINE 100 BID X5-10 DAYS
CLINDAMYCIN 300-450 BID X 5-7 DAYS
TINEA VERSICOLOR
BECOMES APPARENT INI SUMMER WHEN PT TANS J
AFFECTED AREAS DO NOT TAN
APPEAR ON CHEST AND BACK
TREAT WITH ORAL ANTIFUNGAL AGENT OR TOPICAL SELENIUM SULFIDE
Zuletzt geändertvor einem Jahr